WOW!
This whistleblower testimony raises serious probity concerns on another of @boulware_dr's trials "designed to fail".... this time the ACTIV-6 IVM trial.
It is not possible that this trial could have shown a benefit.
And a reminder that @boulware_dr was involved in another trial that "killed off" #hydroxychloroquine in 2020 for similar reasons.
In that study he "forgot" to declare his relationship with Gilead and then went overboard on the next paper. Methinks thou dost protest too much?
In that same trial Boulware claimed that they used folic acid as a placebo "because it was similar in appearance to hydroxychloroquine"
That was not true. See for yourself.
The problem is that folic acid is an active treatment candidate.
So, what are the odds that the Boulware study happened to choose a "placebo" that was subsequently (and preemptively) known to be a furin inhibitor when a study was being conducted into a treatment for the only sars-like virus with a furin site?
And of course, in the final coincidence the Boulware study was published in the same journal - the infamous @NEJM that published the diabolical #surgisphere#lancetgate fraud.
This was gross misinformation.
Why is a @UKHSA staffer who is not a doctor giving medical advice that she doesn't understand the clinical implications of?
Is there rampant bias at the UKHSA? @profnfenton@MartinNeil9
This is serious. If the @UKHSA staff have inherent bias and are then found to be misrepresenting the UK's vaccine surveillance data to oversell an ineffective and unsafe vaccine, people could have died as result.